Joint and Bone Health

Parathyroid Hormone (PTH 1-34)

Parathyroid Hormone (PTH 1-34), also known as Teriparatide, is a synthetic form of the active region of human parathyroid hormone. It is primarily used for improving bone density and strength by stimulating bone formation.

Key Features

• Bone Regeneration: Promotes osteoblast activity for new bone growth.

• Clinically Approved: Widely studied and used for treating osteoporosis.

Benefits

• Increased Bone Density: Reduces the risk of fractures in individuals with osteoporosis.

• Joint Support: Strengthens the bone structure supporting joints.

• Faster Healing: Speeds recovery from bone injuries or fractures.

Usage

• Dosage: Typically 20 mcg per day.

• Administration: Subcutaneous injection.

• Duration: Limited to 2 years of continuous use due to potential side effects.

Osteogenic Growth Peptide (OGP)

Osteogenic Growth Peptide is a naturally occurring peptide involved in the regulation of bone formation and remodeling. It enhances the healing process of fractures and supports overall bone health.

Key Features

• Bone Healing: Accelerates recovery from fractures.

• Collagen Stimulation: Enhances the production of collagen for better joint and bone support.

Benefits

• Faster Fracture Recovery: Reduces healing time for broken bones.

• Joint Support: Promotes healthier joints by improving bone-cartilage interaction.

• Bone Strength: Increases bone density and resistance to injury.

Usage

• Dosage: Experimental ranges from 10-50 mcg per injection.

• Administration: Subcutaneous or intramuscular injection.

• Note: Often studied in combination with other growth factors.